Загрузка...
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
PURPOSE: Migraine can negatively impact patient functioning and quality of life. Here, we report the effects of galcanezumab (GMB), a humanized monoclonal antibody that binds to calcitonin gene-related peptide, on patient-reported outcome (PRO) measures in migraine. METHODS: CGAJ was a Phase III, ra...
Сохранить в:
| Опубликовано в: : | Qual Life Res |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer International Publishing
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886775/ https://ncbi.nlm.nih.gov/pubmed/32944843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11136-020-02632-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|